期刊文献+

子波分析在认知功能障碍脑电信号研究中的应用

下载PDF
导出
摘要 本文介绍了一种新的信号分析方法——子波分析在认知功能障碍脑电信号研究中的应用。重点介绍近年来子波分析在认知功能障碍患者自发、睡眠、不同刺激和工作任务下脑电信号定量特征及动态演变规律的研究中的新进展。研究显示,子波分析是一种适合于认知功能脑电信号研究的新方法,通过子波分析发现了一些有助于早期诊断和预后评估的神经电生理指标。
出处 《国际神经病学神经外科学杂志》 2011年第4期344-348,共5页 Journal of International Neurology and Neurosurgery
  • 相关文献

参考文献32

  • 1Liu, HC, Hu CJ, Tang YC, et al. A pilot study for circadi- an gene disturbance in dementia patients. Neurosci Lett, 2008, 435(3) : 229-233.
  • 2Kada S. Radiographers' attitudes towards persons with de- mentia. Eur J Radiography, 2009, 1(4): 163-168.
  • 3吕志迈,徐运.β淀粉样蛋白代谢相关基因与阿尔茨海默病的研究进展[J].国际神经病学神经外科学杂志,2007,34(6):527-530. 被引量:6
  • 4Stiphane M. A theory multiresolution signal decomposition: the wavelet representation. IEEE Tran, 1959, 11 (7) :674-693.
  • 5Farge M. Wavelet transforms and their applications to turbu- lence. Annu Review Fluid Mech, 1992, 24: 395-457.
  • 6Effern A, Lehnertz K, Fernandez K, et al. Single trial anal- ysis of event related potentials: non-linear de-noising with wavelets. Clin Neurophysiol, 2000 , 111 ( 12 ) : 2255- 2263.
  • 7Adeli H, Zhou Z, Dadmehr N. Analysis of EEG records in an epileptic patient using wavelet transform. J Neurosci Meth- od, 2003, 123(1) : 69-87.
  • 8Senhadji L, Wendling F. Epleptic transient detection: wave- lets and time-frequency approaches. Neurophysiol Clin, 2002, 32(3): 175-192.
  • 9Turner S, Picton P, Campbell J. Extraction of short-latency evoked potentials using a combination of wavelet and evolution- ary algorithms. Med Eng Phys, 2003, 25 ( 5 ) : 407- 412.
  • 10Quiroga, R. Quian; Garcia, H. Single-triM event-related potentials with wavelet denoising. Clin Neurophysiol, 2003, 114(2) : 376-390.

二级参考文献25

  • 1Blennow K, de Leon MJ, Zetterberg H. Alzheimer′s disease. Lancet, 2006, 368(9533) : 387-403.
  • 2Tanzi RE, Bertram L. Twenty Years of the Alzheimer′s Disease Amyloid Hypothesis: A Genetic Perspective. Cell, 2005, 120(4): 545-555.
  • 3Swerdlow RH. Is aging part of Alzheimer′s disease, or is Alzheimer′s disease part of aging? Neurobiol Aging, 2007 , 28(10) : 1465-1480.
  • 4Holsinger RM, Lee JS, Boyd A, et al. CSF BACEI activity is increased in CJD and Alzheimer disease versus other dementias. Neurology, 2006, 67(4): 710-712.
  • 5Blennow K. Cerebrospinal fluid protein biomarkers for Alzheimer′s disease. NeuroRX, 2004, 1(2) : 213-225.
  • 6Sunderland T, Linker G, Mirza N, et al. Decreased betaamyloid 1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA, 2003 , 289( 16 ) : 2094-2103.
  • 7Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer′s AβPeptide : The Many Roads to Perdition. Neuron, 2004, 43 (5) : 605-608.
  • 8Wang Y J, Zhou HD, Zhou XF. Clearance of amyloid-beta in Alzheimer′s disease: progress, problems and perspectives. Drug Discov Today, 2006, 11 (19-20) : 931-938.
  • 9Anon. Consensus report of the Working Group on molecular and biochemical markers of Alzheimer′s disease: the Ronald and Nancy Reagan Research Institute of the Alzheimer′s Association and the National Institute on Aging Working Group. Neurobiol Aging, 1998, 19(2) : 109-116.
  • 10LeVine H 3rd. The Amyloid Hypothesis and the clearance and degradation of Alzheimer′s beta-peptide. J Alzheimers Dis, 2004, 6(3) : 303-314.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部